Introduction
Although five-year survival rates for childhood cancer have surpassed
85%, childhood cancer survivors continue to suffer from long-term
effects decades after treatment completion. The prevalence of pulmonary
dysfunction is very common at 65.2% in adulthood. This study explores
early changes in the trajectory of pulmonary function in pediatric
cancer patients who received pulmonary toxic therapy.